These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7340013)

  • 1. Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture system.
    Schmid BP; Goulding E; Kitchin K; Sanyal MK
    Toxicology; 1981; 22(3):235-43. PubMed ID: 7340013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the embryotoxicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro.
    Slott VL; Hales BF
    Biochem Pharmacol; 1987 Jun; 36(12):2019-25. PubMed ID: 3593406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of rat embryos in culture against the embryotoxicity of acrolein using exogenous glutathione.
    Slott VL; Hales BF
    Biochem Pharmacol; 1987 Jul; 36(13):2187-94. PubMed ID: 3606635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The embryolethality and teratogenicity of acrolein in cultured rat embryos.
    Slott VL; Hales BF
    Teratology; 1986 Oct; 34(2):155-63. PubMed ID: 3775668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
    Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
    Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the cyclophosphamide metabolite acrolein in mammalian limb bud cultures.
    Stahlmann R; Bluth U; Neubert D
    Arch Toxicol; 1985 Aug; 57(3):163-7. PubMed ID: 3933456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the 4-hydroxy intermediate in the in vitro embryotoxicity of cyclophosphamide and dechlorocyclophosphamide.
    Slott VL; Hales BF
    Toxicol Appl Pharmacol; 1988 Feb; 92(2):170-8. PubMed ID: 3341031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The embryotoxicity of the cyclophosphamide metabolite acrolein in rabbits, tested in vivo by i.v. injection and by the yolk-sac method.
    Claussen U; Hellmann W; Pache G
    Arzneimittelforschung; 1980; 30(12):2080-3. PubMed ID: 7194065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of cyclophosphamide in a culture of rat postimplantation embryos].
    Popov VB
    Ontogenez; 1981; 12(3):251-6. PubMed ID: 7254765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of intracellular glutathione in rat embryos and visceral yolk sacs and its effect on 2-nitrosofluorene-induced malformations in the whole embryo culture system.
    Harris C; Namkung MJ; Juchau MR
    Toxicol Appl Pharmacol; 1987 Mar; 88(1):141-52. PubMed ID: 3564029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrolein and embryogenesis: an experimental study.
    Chhibber G; Gilani SH
    Environ Res; 1986 Feb; 39(1):44-9. PubMed ID: 3943510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide teratogenesis: a review.
    Mirkes PE
    Teratog Carcinog Mutagen; 1985; 5(2):75-88. PubMed ID: 2859667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro murine embryotoxicity of cyclophosphamide in embryos co-cultured with maternal hepatocytes: development and application of a murine embryo-hepatocyte co-culture model.
    Ozolins TR; Oglesby LA; Wiley MJ; Wells PG
    Toxicology; 1995 Sep; 102(3):259-74. PubMed ID: 7482566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
    Chen B; Cyr DG; Hales BF
    Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H; Jacob-Müller U
    Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.